COVID-19 Outbreak-Global Nuclear Medicine-Radiopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

1 Nuclear Medicine-Radiopharmaceuticals Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Nuclear Medicine-Radiopharmaceuticals

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Nuclear Medicine-Radiopharmaceuticals industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global Nuclear Medicine-Radiopharmaceuticals Market Size, 2015 – 2020

2.1.2 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Type, 2015 – 2020

2.1.3 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Application, 2015 – 2020

2.1.4 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on Nuclear Medicine-Radiopharmaceuticals Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of Nuclear Medicine-Radiopharmaceuticals Analysis

3.2 Major Players of Nuclear Medicine-Radiopharmaceuticals

3.3 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals

3.3.3 Labor Cost of Nuclear Medicine-Radiopharmaceuticals

3.4 Market Distributors of Nuclear Medicine-Radiopharmaceuticals

3.5 Major Downstream Buyers of Nuclear Medicine-Radiopharmaceuticals Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global Nuclear Medicine-Radiopharmaceuticals Market, by Type

4.1 Global Nuclear Medicine-Radiopharmaceuticals Value and Market Share by Type (2015-2020)

4.2 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Type (2015-2020)

4.3 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate by Type (2015-2020)

4.3.1 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate of Diagnostic Medicine

4.3.2 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate of Therapeutic Medicine

4.4 Global Nuclear Medicine-Radiopharmaceuticals Price Analysis by Type (2015-2020)

5 Nuclear Medicine-Radiopharmaceuticals Market, by Application

5.1 Downstream Market Overview

5.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2015-2020)

5.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of SPECT (2015-2020)

5.3.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of PET (2015-2020)

5.3.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of Therapeutic (2015-2020)

6 Global Nuclear Medicine-Radiopharmaceuticals Market Analysis by Regions

6.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Regions

6.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)

6.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue by Regions (2015-2020)

6.2 North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.3 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

6.6 South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7 North America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries

7.2.1 North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

7.2.2 North America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)

7.3 United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.4 Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

7.5 Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries

8.2.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

8.2.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)

8.3 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.4 UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.5 France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.6 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.7 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

8.8 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

9.2.2 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)

9.3 China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.4 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.5 South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.6 India Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

9.8 Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

10.2.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)

10.3 Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.4 UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.5 Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.6 Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

10.7 South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

11 South America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries

11.2.1 South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

11.2.2 South America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)

11.3 Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

11.4 Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

11.5 Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

11.6 Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 Triad Isotopes, Inc. (US)

12.1.1 Triad Isotopes, Inc. (US) Basic Information

12.1.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.1.3 Triad Isotopes, Inc. (US) Production, Value, Price, Gross Margin 2015-2020

12.2 Medi-Radiopharma Ltd (Hungary)

12.2.1 Medi-Radiopharma Ltd (Hungary) Basic Information

12.2.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.2.3 Medi-Radiopharma Ltd (Hungary) Production, Value, Price, Gross Margin 2015-2020

12.3 Advanced Medical Isotope Corporation (US)

12.3.1 Advanced Medical Isotope Corporation (US) Basic Information

12.3.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.3.3 Advanced Medical Isotope Corporation (US) Production, Value, Price, Gross Margin 2015-2020

12.4 Alliance Medical (UK)

12.4.1 Alliance Medical (UK) Basic Information

12.4.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.4.3 Alliance Medical (UK) Production, Value, Price, Gross Margin 2015-2020

12.5 Peregrine Pharmaceuticals, Inc. (US)

12.5.1 Peregrine Pharmaceuticals, Inc. (US) Basic Information

12.5.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.5.3 Peregrine Pharmaceuticals, Inc. (US) Production, Value, Price, Gross Margin 2015-2020

12.6 Actinium Pharmaceuticals Inc (US)

12.6.1 Actinium Pharmaceuticals Inc (US) Basic Information

12.6.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.6.3 Actinium Pharmaceuticals Inc (US) Production, Value, Price, Gross Margin 2015-2020

12.7 Ion Beam Applications S.A (Belgium)

12.7.1 Ion Beam Applications S.A (Belgium) Basic Information

12.7.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.7.3 Ion Beam Applications S.A (Belgium) Production, Value, Price, Gross Margin 2015-2020

12.8 Mallinckrodt Pharmaceuticals (Ireland)

12.8.1 Mallinckrodt Pharmaceuticals (Ireland) Basic Information

12.8.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.8.3 Mallinckrodt Pharmaceuticals (Ireland) Production, Value, Price, Gross Margin 2015-2020

12.9 Siemens Healthcare (US)

12.9.1 Siemens Healthcare (US) Basic Information

12.9.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.9.3 Siemens Healthcare (US) Production, Value, Price, Gross Margin 2015-2020

12.10 Jubilant Pharma (India)

12.10.1 Jubilant Pharma (India) Basic Information

12.10.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.10.3 Jubilant Pharma (India) Production, Value, Price, Gross Margin 2015-2020

12.11 Positron Corporation (US)

12.11.1 Positron Corporation (US) Basic Information

12.11.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.11.3 Positron Corporation (US) Production, Value, Price, Gross Margin 2015-2020

12.12 Bayer HealthCare Medical Care (US)

12.12.1 Bayer HealthCare Medical Care (US) Basic Information

12.12.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.12.3 Bayer HealthCare Medical Care (US) Production, Value, Price, Gross Margin 2015-2020

12.13 Bracco Imaging S.p.A (Italy)

12.13.1 Bracco Imaging S.p.A (Italy) Basic Information

12.13.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.13.3 Bracco Imaging S.p.A (Italy) Production, Value, Price, Gross Margin 2015-2020

12.14 Nordion, Inc. (Canada)

12.14.1 Nordion, Inc. (Canada) Basic Information

12.14.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.14.3 Nordion, Inc. (Canada) Production, Value, Price, Gross Margin 2015-2020

12.15 Lantheus Medical Imaging Inc (US)

12.15.1 Lantheus Medical Imaging Inc (US) Basic Information

12.15.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.15.3 Lantheus Medical Imaging Inc (US) Production, Value, Price, Gross Margin 2015-2020

12.16 Avid Radiopharmaceuticals (US)

12.16.1 Avid Radiopharmaceuticals (US) Basic Information

12.16.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.16.3 Avid Radiopharmaceuticals (US) Production, Value, Price, Gross Margin 2015-2020

12.17 Immunomedics, Inc. (US)

12.17.1 Immunomedics, Inc. (US) Basic Information

12.17.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.17.3 Immunomedics, Inc. (US) Production, Value, Price, Gross Margin 2015-2020

12.18 Cardinal Health, Inc (US)

12.18.1 Cardinal Health, Inc (US) Basic Information

12.18.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.18.3 Cardinal Health, Inc (US) Production, Value, Price, Gross Margin 2015-2020

12.19 Alseres Pharmaceuticals, Inc (US)

12.19.1 Alseres Pharmaceuticals, Inc (US) Basic Information

12.19.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.19.3 Alseres Pharmaceuticals, Inc (US) Production, Value, Price, Gross Margin 2015-2020

12.20 GE Healthcare (UK)

12.20.1 GE Healthcare (UK) Basic Information

12.20.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction

12.20.3 GE Healthcare (UK) Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast

14.1 Global Nuclear Medicine-Radiopharmaceuticals Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Diagnostic Medicine Market Value and Volume Forecast (2020-2025)

14.1.2 Therapeutic Medicine Market Value and Volume Forecast (2020-2025)

14.2 Global Nuclear Medicine-Radiopharmaceuticals Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 SPECT Market Value and Volume Forecast (2020-2025)

14.2.2 PET Market Value and Volume Forecast (2020-2025)

14.2.3 Therapeutic Market Value and Volume Forecast (2020-2025)

14.3 Nuclear Medicine-Radiopharmaceuticals Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

List of Tables and Figures

Figure Product Picture of Nuclear Medicine-Radiopharmaceuticals

Table Product Specification of Nuclear Medicine-Radiopharmaceuticals

Table Nuclear Medicine-Radiopharmaceuticals Key Market Segments

Table Key Players Nuclear Medicine-Radiopharmaceuticals Covered

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size, 2015 – 2025

Table Different Types of Nuclear Medicine-Radiopharmaceuticals

Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) Segment by Type from 2015-2020

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Types in 2019

Table Different Applications of Nuclear Medicine-Radiopharmaceuticals

Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) Segment by Applications from 2015-2020

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Applications in 2019

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Regions in 2019

Figure North America Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)

Figure Asia Pacific Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)

Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)

Figure South America Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020)

Table Global COVID-19 Status and Economic Overview

Figure Global COVID-19 Status

Figure COVID-19 Comparison of Major Countries

Figure Industry Chain Analysis of Nuclear Medicine-Radiopharmaceuticals

Table Upstream Raw Material Suppliers of Nuclear Medicine-Radiopharmaceuticals with Contact Information

Table Major Players Headquarters, and Service Area of Nuclear Medicine-Radiopharmaceuticals

Figure Major Players Production Value Market Share of Nuclear Medicine-Radiopharmaceuticals in 2019

Table Major Players Nuclear Medicine-Radiopharmaceuticals Product Types in 2019

Figure Production Process of Nuclear Medicine-Radiopharmaceuticals

Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals

Figure Channel Status of Nuclear Medicine-Radiopharmaceuticals

Table Major Distributors of Nuclear Medicine-Radiopharmaceuticals with Contact Information

Table Major Downstream Buyers of Nuclear Medicine-Radiopharmaceuticals with Contact Information

Table Global Nuclear Medicine-Radiopharmaceuticals Value ($) by Type (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Value Share by Type (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Value Share by Type (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Production by Type (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Production Share by Type (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Production Share by Type (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate of Diagnostic Medicine (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate of Therapeutic Medicine (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Price by Type (2015-2020)

Figure Downstream Market Overview

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption by Application (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of SPECT (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of PET (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of Therapeutic (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Regions (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Regions (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2015

Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2019

Figure North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure North America COVID-19 Status

Figure North America COVID-19 Confirmed Cases Major Distribution

Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)

Table North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

Table North America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table North America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)

Table North America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Europe COVID-19 Status

Figure Europe COVID-19 Confirmed Cases Major Distribution

Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)

Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Asia Pacific COVID-19 Status

Figure Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)

Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)

Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure India Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Middle East Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)

Table Middle East Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)

Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure South America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020)

Table South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)

Table South America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table South America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020)

Table South America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Figure Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)

Figure Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)

Figure Top 3 Market Share of Nuclear Medicine-Radiopharmaceuticals Companies in 2019

Figure Top 6 Market Share of Nuclear Medicine-Radiopharmaceuticals Companies in 2019

Table Major Players Production Value ($) Share (2015-2020)

Table Triad Isotopes, Inc. (US) Profile

Table Triad Isotopes, Inc. (US) Product Introduction

Figure Triad Isotopes, Inc. (US) Production and Growth Rate

Figure Triad Isotopes, Inc. (US) Value ($) Market Share 2015-2020

Table Medi-Radiopharma Ltd (Hungary) Profile

Table Medi-Radiopharma Ltd (Hungary) Product Introduction

Figure Medi-Radiopharma Ltd (Hungary) Production and Growth Rate

Figure Medi-Radiopharma Ltd (Hungary) Value ($) Market Share 2015-2020

Table Advanced Medical Isotope Corporation (US) Profile

Table Advanced Medical Isotope Corporation (US) Product Introduction

Figure Advanced Medical Isotope Corporation (US) Production and Growth Rate

Figure Advanced Medical Isotope Corporation (US) Value ($) Market Share 2015-2020

Table Alliance Medical (UK) Profile

Table Alliance Medical (UK) Product Introduction

Figure Alliance Medical (UK) Production and Growth Rate

Figure Alliance Medical (UK) Value ($) Market Share 2015-2020

Table Peregrine Pharmaceuticals, Inc. (US) Profile

Table Peregrine Pharmaceuticals, Inc. (US) Product Introduction

Figure Peregrine Pharmaceuticals, Inc. (US) Production and Growth Rate

Figure Peregrine Pharmaceuticals, Inc. (US) Value ($) Market Share 2015-2020

Table Actinium Pharmaceuticals Inc (US) Profile

Table Actinium Pharmaceuticals Inc (US) Product Introduction

Figure Actinium Pharmaceuticals Inc (US) Production and Growth Rate

Figure Actinium Pharmaceuticals Inc (US) Value ($) Market Share 2015-2020

Table Ion Beam Applications S.A (Belgium) Profile

Table Ion Beam Applications S.A (Belgium) Product Introduction

Figure Ion Beam Applications S.A (Belgium) Production and Growth Rate

Figure Ion Beam Applications S.A (Belgium) Value ($) Market Share 2015-2020

Table Mallinckrodt Pharmaceuticals (Ireland) Profile

Table Mallinckrodt Pharmaceuticals (Ireland) Product Introduction

Figure Mallinckrodt Pharmaceuticals (Ireland) Production and Growth Rate

Figure Mallinckrodt Pharmaceuticals (Ireland) Value ($) Market Share 2015-2020

Table Siemens Healthcare (US) Profile

Table Siemens Healthcare (US) Product Introduction

Figure Siemens Healthcare (US) Production and Growth Rate

Figure Siemens Healthcare (US) Value ($) Market Share 2015-2020

Table Jubilant Pharma (India) Profile

Table Jubilant Pharma (India) Product Introduction

Figure Jubilant Pharma (India) Production and Growth Rate

Figure Jubilant Pharma (India) Value ($) Market Share 2015-2020

Table Positron Corporation (US) Profile

Table Positron Corporation (US) Product Introduction

Figure Positron Corporation (US) Production and Growth Rate

Figure Positron Corporation (US) Value ($) Market Share 2015-2020

Table Bayer HealthCare Medical Care (US) Profile

Table Bayer HealthCare Medical Care (US) Product Introduction

Figure Bayer HealthCare Medical Care (US) Production and Growth Rate

Figure Bayer HealthCare Medical Care (US) Value ($) Market Share 2015-2020

Table Bracco Imaging S.p.A (Italy) Profile

Table Bracco Imaging S.p.A (Italy) Product Introduction

Figure Bracco Imaging S.p.A (Italy) Production and Growth Rate

Figure Bracco Imaging S.p.A (Italy) Value ($) Market Share 2015-2020

Table Nordion, Inc. (Canada) Profile

Table Nordion, Inc. (Canada) Product Introduction

Figure Nordion, Inc. (Canada) Production and Growth Rate

Figure Nordion, Inc. (Canada) Value ($) Market Share 2015-2020

Table Lantheus Medical Imaging Inc (US) Profile

Table Lantheus Medical Imaging Inc (US) Product Introduction

Figure Lantheus Medical Imaging Inc (US) Production and Growth Rate

Figure Lantheus Medical Imaging Inc (US) Value ($) Market Share 2015-2020

Table Avid Radiopharmaceuticals (US) Profile

Table Avid Radiopharmaceuticals (US) Product Introduction

Figure Avid Radiopharmaceuticals (US) Production and Growth Rate

Figure Avid Radiopharmaceuticals (US) Value ($) Market Share 2015-2020

Table Immunomedics, Inc. (US) Profile

Table Immunomedics, Inc. (US) Product Introduction

Figure Immunomedics, Inc. (US) Production and Growth Rate

Figure Immunomedics, Inc. (US) Value ($) Market Share 2015-2020

Table Cardinal Health, Inc (US) Profile

Table Cardinal Health, Inc (US) Product Introduction

Figure Cardinal Health, Inc (US) Production and Growth Rate

Figure Cardinal Health, Inc (US) Value ($) Market Share 2015-2020

Table Alseres Pharmaceuticals, Inc (US) Profile

Table Alseres Pharmaceuticals, Inc (US) Product Introduction

Figure Alseres Pharmaceuticals, Inc (US) Production and Growth Rate

Figure Alseres Pharmaceuticals, Inc (US) Value ($) Market Share 2015-2020

Table GE Healthcare (UK) Profile

Table GE Healthcare (UK) Product Introduction

Figure GE Healthcare (UK) Production and Growth Rate

Figure GE Healthcare (UK) Value ($) Market Share 2015-2020

Table Market Driving Factors of Nuclear Medicine-Radiopharmaceuticals

Table Merger, Acquisition and New Investment

Table Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) Forecast, by Type

Table Global Nuclear Medicine-Radiopharmaceuticals Market Volume Forecast, by Type

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Diagnostic Medicine (2020-2025)

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Diagnostic Medicine (2020-2025)

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Therapeutic Medicine (2020-2025)

Figure Global Nuclear Medicine-Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Therapeutic Medicine (2020-2025)

Table Global Market Value ($) Forecast by Application (2020-2025)

Table Global Market Volume Forecast by Application (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of SPECT (2020-2025)

Figure Market Volume and Growth Rate Forecast of SPECT (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of PET (2020-2025)

Figure Market Volume and Growth Rate Forecast of PET (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Therapeutic (2020-2025)

Figure Market Volume and Growth Rate Forecast of Therapeutic (2020-2025)

Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure North America Consumption and Growth Rate Forecast (2020-2025)

Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Europe Consumption and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)

Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure South America Consumption and Growth